Dan Brennan
Stock Analyst at TD Cowen
(4.06)
# 514
Out of 5,147 analysts
133
Total ratings
50.98%
Success rate
13.07%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Buy | $170 → $157 | $121.38 | +29.35% | 14 | Feb 26, 2026 | |
| XGN Exagen | Maintains: Buy | $13 → $10 | $3.62 | +176.24% | 1 | Feb 24, 2026 | |
| GH Guardant Health | Maintains: Buy | $130 → $135 | $93.90 | +43.77% | 4 | Feb 20, 2026 | |
| BRKR Bruker | Maintains: Hold | $53 → $43 | $40.11 | +7.21% | 4 | Feb 13, 2026 | |
| TXG 10x Genomics | Maintains: Hold | $18 → $19 | $23.05 | -17.57% | 6 | Feb 13, 2026 | |
| RVTY Revvity | Maintains: Buy | $120 → $124 | $98.31 | +26.13% | 4 | Feb 3, 2026 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $696 → $683 | $521.11 | +31.07% | 15 | Jan 30, 2026 | |
| ILMN Illumina | Maintains: Hold | $115 → $140 | $134.46 | +4.12% | 14 | Jan 7, 2026 | |
| DHR Danaher | Maintains: Buy | $260 → $270 | $210.64 | +28.18% | 7 | Jan 7, 2026 | |
| AVTR Avantor | Maintains: Hold | $14 → $12 | $9.05 | +32.60% | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $7 | $3.40 | +105.88% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $345 → $390 | $319.38 | +22.11% | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $74 → $90 | $103.38 | -12.94% | 7 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $8 → $9 | $4.61 | +95.23% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $9.83 | +22.08% | 7 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $16.02 | -6.37% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $20.14 | +58.89% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $110 | $79.71 | +38.00% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $2.5 | $3.56 | -29.78% | 4 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $74 | $53.25 | +38.97% | 2 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $175 | $208.04 | -15.88% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $250 | $178.49 | +40.06% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $50.14 | +1.72% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $56 | $15.33 | +265.30% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $185.17 | +194.86% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.68 | +792.86% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $108.14 | +114.54% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,366.69 | -35.61% | 3 | Oct 7, 2020 |
Agilent Technologies
Feb 26, 2026
Maintains: Buy
Price Target: $170 → $157
Current: $121.38
Upside: +29.35%
Exagen
Feb 24, 2026
Maintains: Buy
Price Target: $13 → $10
Current: $3.62
Upside: +176.24%
Guardant Health
Feb 20, 2026
Maintains: Buy
Price Target: $130 → $135
Current: $93.90
Upside: +43.77%
Bruker
Feb 13, 2026
Maintains: Hold
Price Target: $53 → $43
Current: $40.11
Upside: +7.21%
10x Genomics
Feb 13, 2026
Maintains: Hold
Price Target: $18 → $19
Current: $23.05
Upside: -17.57%
Revvity
Feb 3, 2026
Maintains: Buy
Price Target: $120 → $124
Current: $98.31
Upside: +26.13%
Thermo Fisher Scientific
Jan 30, 2026
Maintains: Buy
Price Target: $696 → $683
Current: $521.11
Upside: +31.07%
Illumina
Jan 7, 2026
Maintains: Hold
Price Target: $115 → $140
Current: $134.46
Upside: +4.12%
Danaher
Jan 7, 2026
Maintains: Buy
Price Target: $260 → $270
Current: $210.64
Upside: +28.18%
Avantor
Jan 7, 2026
Maintains: Hold
Price Target: $14 → $12
Current: $9.05
Upside: +32.60%
Nov 13, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $3.40
Upside: +105.88%
Nov 5, 2025
Maintains: Hold
Price Target: $345 → $390
Current: $319.38
Upside: +22.11%
Nov 4, 2025
Maintains: Buy
Price Target: $74 → $90
Current: $103.38
Upside: -12.94%
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $9
Current: $4.61
Upside: +95.23%
Sep 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $9.83
Upside: +22.08%
Aug 6, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $16.02
Upside: -6.37%
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $20.14
Upside: +58.89%
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $79.71
Upside: +38.00%
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $3.56
Upside: -29.78%
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $53.25
Upside: +38.97%
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $208.04
Upside: -15.88%
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $178.49
Upside: +40.06%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $50.14
Upside: +1.72%
May 13, 2024
Initiates: Buy
Price Target: $56
Current: $15.33
Upside: +265.30%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $185.17
Upside: +194.86%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.68
Upside: +792.86%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $108.14
Upside: +114.54%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,366.69
Upside: -35.61%